pargyline has been researched along with Diarrhea in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teichmann, G | 1 |
| Thiel, H | 1 |
| Riethling, AK | 1 |
| Völkner, E | 1 |
| Harms, R | 1 |
1 other study available for pargyline and Diarrhea
| Article | Year |
|---|---|
[Gastrointestinal side effects of medicamentous antihypertensive therapy].
Topics: Antihypertensive Agents; Constipation; Diarrhea; Feeding and Eating Disorders; Gastrointestinal Dise | 1971 |